Regenicin Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jan '26 Jan 30, 2026	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018
Market Capitalization	0	0	3	2	3	6
Market Cap Growth	-99.57%	-84.00%	66.67%	-36.84%	-51.41%	-34.83%
Enterprise Value	-	1	4	2	3	6
Last Close Price	0.00	0.00	0.02	0.01	0.02	0.04
PB Ratio	0.00	-0.09	-0.62	-0.43	-0.78	-2.00
Debt / Equity Ratio	-0.10	-0.11	-0.12	-0.13	-0.12	-0.12
Net Debt / Equity Ratio	1.81	-0.11	-0.12	-0.13	-0.12	-0.12
Quick Ratio	0.66	0.00	0.00	0.00	0.00	0.00
Current Ratio	0.66	0.00	0.00	0.00	0.00	0.02
Return on Assets (ROA)	-9.43%	-3738.30%	-9083.77%	-8774.17%	-1491.05%	-683.91%
Return on Capital Employed (ROCE)	14.40%	10.70%	12.80%	15.50%	19.80%	26.30%
Earnings Yield	-6420.32%	-130.16%	-21.85%	-30.38%	-26.01%	-9.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.